Home / SMIM13 Knockout Cell Lines

SMIM13 Knockout Cell Lines

Gene: SMIM13

Official Full Name: small integral membrane protein 13provided by HGNC

Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO27427 SMIM13 Knockout cell line (HeLa) Human SMIM13 1:3~1:6 Negative Online Inquiry
KO27428 SMIM13 Knockout cell line (HCT 116) Human SMIM13 1:2~1:4 Negative Online Inquiry
KO27429 SMIM13 Knockout cell line (HEK293) Human SMIM13 1:3~1:6 Negative Online Inquiry
KO27430 SMIM13 Knockout cell line (A549) Human SMIM13 1:3~1:4 Negative Online Inquiry

Background

SMIM13 Gene Knockout Cell Lines are genetically engineered cell lines that have undergone targeted gene modification to effectively disrupt the expression of the SMIM13 gene. This modification is achieved through the application of cutting-edge CRISPR-Cas9 technology, which allows for precise and efficient editing of the genomic sequence. The resultant cell lines enable researchers to investigate the functional roles of SMIM13 in various biological processes, particularly its implications in cellular homeostasis and disease states.

The key functionality of these knockout cell lines centers around facilitating studies that elucidate the gene’s contributions to normal physiology and pathological conditions. By generating a loss-of-function model, researchers can assess SMIM13’s role in pathways such as cell signaling, metabolic processes, and cellular responses to stress. Such investigations are crucial in uncovering the gene's involvement in diseases like cancer, where aberrations in gene expression may be linked to tumorigenesis and progression.

Scientifically, SMIM13 Gene Knockout Cell Lines hold significant value in both basic and applied research settings. In laboratories focused on molecular biology and genetics, these cell lines serve as essential tools for validating hypotheses regarding gene function and for the screening of potential therapeutic compounds. Furthermore, their use extends into clinical research, where understanding gene interactions can inform treatment strategies and biomarker development.

One of the major advantages of utilizing SMIM13 Gene Knockout Cell Lines is their superior specificity and the robustness of the CRISPR-based approach, which minimizes off-target effects commonly observed with traditional gene knockout methods. This level of precision enhances the reliability of experimental outcomes, fostering more credible data for scientific inquiry. Moreover, our cell lines come with a comprehensive support package, including detailed protocols and validation data, which streamlines the research process for end-users.

For researchers and clinicians looking to deepen their understanding of gene function and its implications in health and disease, SMIM13 Gene Knockout Cell Lines represent an invaluable resource. They embody not only innovation and quality but also the commitment of our company to provide advanced biological products tailored to meet the challenges of modern research. Our expertise in genetic engineering and commitment to scientific excellence ensure that these products are integral to pushing the boundaries of discovery in the life sciences.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.